Intech Biopharm Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Intech Biopharm Ltd

Watchlist Manager

Watchlist

Price: 26.7 TWD 0.95% Market Closed

Market Cap: NT$3.1B

I	Intech Biopharm Ltd TPEX:6461	TW
C	Certain Micro Application Technology Inc TPEX:7899	TW
	Bank of Greece F:BGC	GR
V	V-Tac Technology Co Ltd TPEX:6229	TW
A	ASolid Technology Co Ltd TPEX:6485	TW

Profitability Summary

Intech Biopharm Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-382%

Negative 3Y Average Gross Margin

-362%

Gross Margin is Increasing

-658% > -382%

Negative Operating Margin

-958%

Negative 3Y Average Operating Margin

-806%

Operating Margin is Increasing

-1 307% > -958%

Negative Net Margin

-993%

Negative 3Y Average Net Margin

-845%

Net Margin is Increasing

-1 377% > -993%

Negative Free Cash Flow Margin

-833%

Negative 3Y Average Free Cash Flow Margin

-699%

Free Cash Flow Margin is Increasing

-846% > -833%

Negative ROE

-48%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-17%

Declining ROIC

-15% > -22%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.